Prince Harry appeared in a surprise video for the 2025 WellChild Awards on Tuesday, Jan. 28, and asked people to submit ...

GSK PLC GSK shares advanced 3.35% to £14.02 Monday, on what proved to be an all-around great trading session for the stock ...

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the Marketing Authorisation Application, MAA, for the use ...

Bearish flow noted in GSK (GSK) Pharma with 1,694 puts trading, or 4x expected. Most active are 2/7 weekly 34 puts and Jan-27 28 puts, with total volume in those strikes near 1,600 contracts. The ...

GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...

A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side effects.

Every year, 21.5 million people are forcibly displaced by floods, droughts, wildfires, and storms. This number ...

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...

GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.29 billion and currently ...

GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.31 billion and an impressive gross profit margin of 72.39%, has announced that its new drug applications ...